Sensus Healthcare, Inc.
About Sensus Healthcare, Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $27.5M
- Net income
- -$7.7M
- Total assets
- $53.0M
- Market cap
- $44.4M
- Gross margin
- 43.2%
- Operating margin
- -37.5%
- Net margin
- -28.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $27.5M
- Cost of revenue
- $15.6M
- Gross profit
- $11.9M
- Operating expenses
- $22.2M
- Operating income
- -$10.3M
- Income tax
- -$1.9M
- Net income
- -$7.7M
- EPS (basic)
- $-0.47
- EPS (diluted)
- $-0.47
Balance sheet
- Total assets
- $53.0M
- Current assets
- $45.9M
- Total liabilities
- $4.9M
- Current liabilities
- $4.7M
- Shareholders’ equity
- $48.1M
Cash flow
- Operating cash flow
- $528.0K
- Investing cash flow
- -$196.0K
- Financing cash flow
- -$305.0K
- Net cash flow
- $27.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $44.4M
- EPS (diluted)
- $-0.47
- Shares outstanding
- 16.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 25, 2016
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $7.7M in FY2025.
- Revenue grew 2% from FY2021 to FY2025.
- Gross margin of 43.2%, net margin -28.1%.
- Trading 52% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Sensus Healthcare, Inc..
Write a review
News about Sensus Healthcare, Inc.
News & sentiment via Polygon.io
